Peer-Reviewed Research
Epithalon (also known as Epitalon or AEDG) is a synthetic tetrapeptide derived from epithalamin, a pineal gland peptide complex. Published research has investigated Epithalon in laboratory, animal, and limited human studies involving telomerase activity, telomere biology, cellular senescence, genomic stability, melatonin regulation, and healthy aging. While interest in Epithalon continues to grow, contemporary human clinical evidence remains limited.
Recent Scientific Review
Overview of Epitalon—Highly Bioactive Pineal Tetrapeptide with Promising Properties
Journal: International Journal of Molecular Sciences
Published: 2025
Study Type: Comprehensive scientific review
Summary
This comprehensive review evaluates more than two decades of Epitalon research, including laboratory, animal, and human investigations. The authors discuss proposed mechanisms involving telomerase activation, melatonin regulation, antioxidant activity, genomic stability, immune modulation, and neuroendocrine signaling while emphasizing that additional high-quality clinical studies are needed.
View on PubMed:
https://pubmed.ncbi.nlm.nih.gov/40141333/
Read Full Text:
https://pmc.ncbi.nlm.nih.gov/articles/PMC11943447/
DOI:
https://doi.org/10.3390/ijms26062691
Landmark Original Research
Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells
Journal: Bulletin of Experimental Biology and Medicine
Published: 2003
Study Type: Original laboratory research
Summary
Researchers investigated Epithalon in cultured human fetal fibroblasts. Treatment induced expression of the catalytic subunit of telomerase, increased telomerase activity, and was associated with telomere elongation in the experimental cell model. The findings were generated in cultured cells and do not establish clinical anti-aging effects in humans.
View on PubMed:
https://pubmed.ncbi.nlm.nih.gov/12937682/
DOI:
https://doi.org/10.1023/A:1025493705728
Peptide Promotes Overcoming of the Division Limit in Human Somatic Cell
Journal: Bulletin of Experimental Biology and Medicine
Published: 2004
Study Type: Original laboratory research
Summary
This study evaluated whether Epithalon influenced the replicative lifespan of cultured human somatic cells. Investigators reported prolonged cellular proliferation under laboratory conditions, supporting continued investigation into cellular aging mechanisms. These findings remain limited to experimental cell culture.
DOI:
https://doi.org/10.1023/B:BEBM.0000038164.49947.8C
Effects of Short Peptides on Lymphocyte Chromatin in Senile Subjects
Journal: Bulletin of Experimental Biology and Medicine
Published: 2004
Study Type: Human laboratory research
Summary
Researchers examined chromatin changes in lymphocytes obtained from older adults following treatment with short peptide bioregulators, including Epithalon. The study explored age-related chromatin remodeling and genomic stability but was not designed to evaluate clinical outcomes.
DOI:
https://doi.org/10.1023/B:BEBM.0000024393.40560.05
Recent Original Research
Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity
Journal: Aging
Published: 2025
Study Type: Original laboratory research
Summary
This recent study investigated Epitalon in normal human epithelial cells, fibroblasts, and breast cancer cell lines. Researchers observed increases in telomere length in multiple cell lines and examined potential mechanisms involving hTERT expression, telomerase activity, and alternative lengthening of telomeres (ALT) pathways. The work provides new mechanistic evidence but remains an in vitro investigation rather than a human clinical study.
Read Full Text:
https://pmc.ncbi.nlm.nih.gov/articles/PMC12411320/
Additional Epithalon Publications
Browse current PubMed research:
https://pubmed.ncbi.nlm.nih.gov/?term=Epitalon
Research Disclaimer
The information presented in this Research Library is provided for educational and scientific reference purposes only and is based on published peer-reviewed research. Research findings continue to evolve, and investigational compounds may not be approved for clinical use. All Pearland Peptides products are supplied For Research Use Only and are not intended for human consumption, diagnosis, treatment, cure, or prevention of any disease.